(Columbus, OH April 25, 2024) - The Midwest Pediatric Device Consortium (MPDC), led by Nationwide Children’s Hospital, The Ohio State University, Cincinnati Children’s, and Cleveland Clinic Children’s is the result of an initiative from the Food and Drug Administration (FDA) that focuses on increasing pediatric device development and providing resource funding for inventors and their projects.
The consortium has announced its first grant recipients working to advance pediatric medical devices into clinical use.
Awardees receiving a $50,000 grant:
|
Organization |
Project |
|
Los Angeles, CA |
Spinal Cord Innovation in Pediatrics (SCiP™), a novel device proven to treat the root cause of cerebral palsy through spinal cord neuromodulation.
|
|
Evanston, IL |
FlowSense, a noninvasive wireless, wearable skin patch that can assess and monitor fluid flow below the skin surface. The company is initially targeting hydrocephalus, a life-threatening condition caused by an abnormal accumulation of cerebrospinal fluid (CSF).
|
|
Cleveland, OH |
A laser otoscope providing an enhanced illumination source for more accurately diagnosing otitis media with effusion (chronic ear infection).
|
Awardees receiving a $25,000 grant:
|
Organization |
Project |
|
Offices in Indiana and Louisiana |
Acoustic levitation technology for small sample volume comprehensive blood coagulation analysis |
|
Texas |
Revolutionizing pediatric heart preservation using the VP.S ENCORE® PEDS Device
|
The FDA awarded a $6.95 million grant to establish the MPDC. “This was a major achievement in our first year, and highlights the hard work of the MPDC members, partners and our comprehensive Advisory Council,” said Cory Criss, MD, co-principal investigator and chief operating officer of the consortium and pediatric surgeon at Nationwide Children’s.
“This was a very competitive process, and we are committed to investing in the success of all members of the MPDC portfolio,” mentioned David Eckmann, MD, PhD, chief executive officer of the consortium. All applicants will meet with the MPDC Needs Assessment Committee to evaluate and provide feedback, direction, and utilization of additional resources within the consortium. This collaboration not only advances pediatric devices here in the Midwest, but also has the potential to improve care and outcomes for kids around the world. Learn more about the consortium in Pediatrics Nationwide.
About MPDC
The Midwest Pediatric Device Consortium (MPDC) is a consortium led by Nationwide Children’s Hospital and The Ohio State University to develop, produce, and commercialize pediatric medical devices. The MPDC is the first of its kind in the Midwest and is supported by a $6.95 million grant from the Food and Drug Administration (FDA), and led by investigators from Nationwide Children’s, Ohio State, Cincinnati Children’s, Cleveland Clinic Children’s, and many of the other major health care centers, academic institutions and industries across the Midwest. With the knowledge and support of industry leaders committed to the MPDC, the number of pediatric medical devices across the nation will continue to increase.
###